Politicians have heaped fire and brimstone upon pharmaceutical companies for increasing the price of their products, some of which were approved decades ago. But far less ire has been directed at price tags on newly approved treatments — many of which continue to rise.
New cancer drugs cost about 17 times more than they did 40 years ago, according to Kaiser Health News, and a drug for spinal muscular atrophy approved in 2016 is one of the most expensive products on the market, the Boston Globe reported.
LINK: https://www.statnews.com/2017/03/30/drug-prices-new-approved/
